Prevalence of Functional Lower Urinary Tract Voiding Dysfunction in School-Aged Children

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age4-14
SponsorTanta University

About this trial

The aim of this study is to investigate the prevalence of voiding disorders and the related risk factors for the primary school-age children in El Ghrbia Government

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Children aged 4-14 years old in our locality.

Disqualifiers

Children with known anatomical anomalies of urinary tract

Children with known neurological anomalies (spinal dysraphism, multiple sclerosis, lumbar or spinal neuritis……… etc)

Children with history of back or lower urinary tract trauma

Parents who refuse participation

Trial population

School-aged children (4-14 years) attending primary schools in El Gharbia Governorate, Egypt, during the study period.

Trial design

Design model

Cohort

Time perspective

Cross-sectional

Treatments tested in this trial

  • Arabic Dysfunctional Voiding Symptom Score Questionnaire (DVSS)

    Other intervention

    A validated Arabic version of the Dysfunctional Voiding Symptom Score Questionnaire (DVSS) questionnaire will be used to screen children for symptoms of lower urinary tract dysfunction. It includes 10 items assessing urinary and bowel habits.

Treatment groups

500 Participants
are divided into 1 treatment group
Group A: Study group1 intervention

Trial outcomes

Primary outcomes

1

Prevalence of Voiding Dysfunction

Prevalence of Voiding Dysfunction Among School-Aged Children will be Measured using the validated Arabic version of the Dysfunctional Voiding Symptom Score (DVSS). Children with a score above the diagnostic threshold will be considered as having voiding dysfunction.

Time frame
1 Hour after completion of the questionnaire

Secondary outcomes

1

Frequency of Constipation in Children With Voiding Dysfunction

Constipation history will be identified through the Dysfunctional Voiding Symptom Score (DVSS) questionnaire and confirmed during clinical evaluation.

Time frame
1 Hour after completion of the questionnaire

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: